The role of somatic symptoms in treatment choice and PTSD outcomes
Faculty Sponsor(s)
Jacob Bentley, Ph.D.
Presentation Type
Event
Project Type
Completed quantitative research study
Primary Department
Clinical Psychology
Description
Post-Traumatic Stress Disorder (PTSD) affects approximately 8-14% of the US population. PTSD symptoms include irritability, flashbacks, guilt, loss of sleep, and hypervigilance. Some experiences more somatic symptoms than others, including dizziness, muscle pain, gastro-intestinal issues, and headaches. These individuals often seek advice from medical practitioners which may potentially cause them to seek pharmacological treatments as opposed to other cognitive-based interventions such as Prolonged Exposure (PE). The purpose of this study is to examine how somatic symptoms influence PTSD treatment choice and outcomes. Because very few studies have examined treatment preference for PTSD patients experiencing somatic symptoms, more research is warranted.
Copyright Status
http://rightsstatements.org/vocab/InC/1.0/
Additional Rights Information
Copyright held by author(s).
The role of somatic symptoms in treatment choice and PTSD outcomes
Post-Traumatic Stress Disorder (PTSD) affects approximately 8-14% of the US population. PTSD symptoms include irritability, flashbacks, guilt, loss of sleep, and hypervigilance. Some experiences more somatic symptoms than others, including dizziness, muscle pain, gastro-intestinal issues, and headaches. These individuals often seek advice from medical practitioners which may potentially cause them to seek pharmacological treatments as opposed to other cognitive-based interventions such as Prolonged Exposure (PE). The purpose of this study is to examine how somatic symptoms influence PTSD treatment choice and outcomes. Because very few studies have examined treatment preference for PTSD patients experiencing somatic symptoms, more research is warranted.
Rights Statement
